Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Circulating toxins/proteins in plasma" is not the name of a single molecular target but rather refers broadly to the diverse array of **proteins** and **potentially toxic molecules** present within blood plasma. These include physiological components such as albumin, immunoglobulins, clotting factors, transporters like lipoproteins, acute-phase reactants involved in inflammation, and pathological entities such as misfolded monoclonal immunoglobulins seen in certain cancers or exogenous/endogenous toxins. Plasma proteins play essential roles in transport functions (lipids by lipoproteins), immune defense (immunoglobulins), hemostasis (clotting factors), maintenance of oncotic pressure (albumin), and modulation of inflammation. Some can become pathogenic when abnormally expressed or structurally altered—such as monoclonal light chains causing amyloidosis or myeloma kidney injury—or when they act as mediators/biomarkers for diseases including cardiovascular conditions, autoimmune disorders, cancer, neurodegeneration, among others. Therapeutically relevant interventions may involve replacing deficient beneficial proteins using purified/recombinant products, removing harmful ones through plasmapheresis/exchange transfusion procedures, or targeting them pharmacologically if they drive pathology. Because "circulating toxins/proteins in plasma" is an umbrella term rather than a specific molecule/receptor entity—and encompasses hundreds to thousands of distinct targets—it is **not considered a canonical therapeutic target** itself but rather describes a class/category that includes many individual targets with unique properties. If you require structured information on any *specific* circulating protein/toxin—such as "albumin," "factor VIII," "serum amyloid A," etc.—please specify the exact molecule for detailed data extraction.
For therapeutics targeting specific plasma proteins/toxins: Replacement therapy for deficient coagulation factors restores missing factor to enable normal coagulation. For removal of circulating toxins/proteins: Plasmapheresis removes pathogenic substances from circulation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Circulating toxin or protein in plasma.